https://prabadinews.com/
  • October 7, 2026
  • Last Update July 17, 2026 9:28 pm
  • United States of America

Luspatercept-Aamt Shows Clinically Meaningful Benefits in Reducing Transfusion Burden and Increasing Hemoglobin

Luspatercept-Aamt Shows Clinically Meaningful Benefits in Reducing Transfusion Burden and Increasing Hemoglobin

Luspatercept shows promise in reducing transfusion dependence for myelofibrosis-associated anemia, despite not meeting primary trial end points.

administrator

Related Articles